Immunosuppression in kidney transplantation
نویسندگان
چکیده
For most patients with chronic kidney failure, kidney transplantation has the greatest potential for restoring a healthy and productive life. The risk of acute rejection is the highest in the first months after transplantation (induction phase) and diminishes afterwards (maintenance phase). Immunosuppression should be at the highest level in the early period and reduced for long-term therapy. At present, conventional immunosuppressive protocols consist of the triple therapy: a calcineurin inhibitor, an adjunctive agent, corticosteroids. The development of new immunosuppressives drugs is aimed not only at improving short-term outcomes, but also achieving better safety, less nephrotoxicity and minimal side effects.
منابع مشابه
Role of Immunosuppression Minimization Protocols in Renal Transplantation
The subject of transplant immunosuppression has generated significant interest in recent years. Excellent immunosuppression, advances in surgical technique, post-transplantation care, and infection control have resulted in excellent outcomes. There is widespread support for the notion that the fundamental objective in transplant immunology should be the achievement of specific graft toleran...
متن کاملTacrolimus and diabetic ketoacidosis after kidney transplantation in a 15-year-old girl (Case Report)
Tacrolimus is a main drug for induction and maintenance immunosuppression for patients with kidney transplants in many centers. One of important side effect of drug is post-transplant diabetes mellitus. Of course, diabetes ketoacidosis (DKA) is rare. In this report, a 12-year-old girl with DKA was presented after 45 days of kidney transplantation.
متن کاملRelationship between post-transplant lymphoproliferative disorder and Anti-Thymocyte Globulin or Anti-Lymphocyte Globulin
Abstract Background: Lymphoproliferative disorders are among the most serious and potentially fatal complications of chronic immunosuppression in kidney transplant recipients. The principle risk factors for development of PTLD are the degree of overall immunosuppression and the EBV serostatus of the recipient. In this study, the risk of PTLD in kidney transplant recipients who received Anti- L...
متن کاملRENAL TRANSPLANTATION A BETTER QUALITY OF LIFE FOR UREMIC PATIENTS, REVIEW OF RESULTS IN 69 KIDNEY TRANSPLANTIONS
Between June, 1984 and January 20, 1987, 69 kidney transplantations were performed in our department. All kidneys were acquired from living donors. 63% of the cases were high-risk MLC-positive (poorly matched), and all but one were from related sources. There were only five rejected kidneys, all of which occurred in kidneys from parent donors. 28 recipients received donor-specific transfus...
متن کاملClinical Pharmacokinetics of Triple Immunosuppression Scheme in Kidney Transplant (Tacrolimus, Mycophenolate Mofetil
Kidney transplantation is now firmly established as the treatment of choice for most patients with End Stage Renal Disease. The short-term outcomes of renal transplantation have dramatically improved over the past several decades; in a large part, this success is due to improvements in immunosuppression and post transplantation medical care. The goal of immunosuppressive strategies in transplan...
متن کاملClinical Pharmacokinetics of Triple Immunosuppression Scheme in Kidney Transplant (Tacrolimus, Mycophenolate Mofetil
Kidney transplantation is now firmly established as the treatment of choice for most patients with End Stage Renal Disease. The short-term outcomes of renal transplantation have dramatically improved over the past several decades; in a large part, this success is due to improvements in immunosuppression and post transplantation medical care. The goal of immunosuppressive strategies in transplan...
متن کامل